NM_004481.5:c.89C>T
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_004481.5(GALNT2):c.89C>T(p.Ala30Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000195 in 1,330,326 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004481.5 missense
Scores
Clinical Significance
Conservation
Publications
- congenital disorder of glycosylation, type iitInheritance: AR Classification: STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALNT2 | NM_004481.5 | c.89C>T | p.Ala30Val | missense_variant | Exon 1 of 16 | ENST00000366672.5 | NP_004472.1 | |
GALNT2 | NR_120373.2 | n.132C>T | non_coding_transcript_exon_variant | Exon 1 of 2 | ||||
GALNT2 | NM_001291866.2 | c.12+9291C>T | intron_variant | Intron 1 of 15 | NP_001278795.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALNT2 | ENST00000366672.5 | c.89C>T | p.Ala30Val | missense_variant | Exon 1 of 16 | 1 | NM_004481.5 | ENSP00000355632.4 | ||
GALNT2 | ENST00000488903.1 | n.111C>T | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 | |||||
GALNT2 | ENST00000494106.1 | n.89+9291C>T | intron_variant | Intron 1 of 6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 149980Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000393 AC: 3AN: 76306 AF XY: 0.0000448 show subpopulations
GnomAD4 exome AF: 0.0000203 AC: 24AN: 1180346Hom.: 1 Cov.: 30 AF XY: 0.0000173 AC XY: 10AN XY: 578444 show subpopulations
GnomAD4 genome AF: 0.0000133 AC: 2AN: 149980Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73198 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.89C>T (p.A30V) alteration is located in exon 1 (coding exon 1) of the GALNT2 gene. This alteration results from a C to T substitution at nucleotide position 89, causing the alanine (A) at amino acid position 30 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 30 of the GALNT2 protein (p.Ala30Val). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with GALNT2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at